Search
Search Results
##search.searchResults.foundPlural##
-
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2367PDF: 1250HTML: 1718CoverLetter: 159 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4535PDF: 2730HTML: 2244 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3130PDF: 1021HTML: 412 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1543PDF: 1134HTML: 182 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3163PDF: 1189HTML: 8082 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1618PDF: 1059HTML: 10688Untitled: 163 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2182PDF: 854HTML: 1980Fig 1 Rossi: 154 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1905PDF: 685HTML: 669Table1: patient's characteristics: 138Table 2: profile of each patient: 163 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1679PDF: 545HTML: 260 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1599PDF: 1128HTML: 229 -
Acquired Hemophilia A successfully treated with rituximab
1845PDF: 1093HTML: 1443Figure 1: 151







